Ablation is defined as the process for restoring normal heart rhythm, particularly if the irregular rhythm has not responded to medication. It is a type of minimally invasive system used by doctors to destroy abnormal tissue that can be present due to various conditions. Laser, radiofrequency, ultrasound, microwave, and others are the various technologies used for ablation. Also, ablation technology is utilized by hospitals and surgical centers, oncology centers, clinics, community healthcare, and others.
Continuously growing advancements in various industries such as medical, surgical centers, oncology centers are helping in the market revenue.. Furthermore, rising government investments in research and development of medical from various countries creates the market for ablation technology. and increasing the demand of in up-coming years. In addition, growing advancement in medical industry creates the market for ablation technology.
Leading companies and various organizations working in the advancement of medical sector have been focusing towards advanced development in ablation technology for offering various advanced features which is based on technologies and market hold. However, high-cost requirement in the deployment and maintenance of devices directly hamper the overall growth of global ablation technology market. Along with that, limited accessibility and shortage in availability creates the hinder for the ablation technology market. Also, hardware component cost is high and higher component prices will, in turn, increase the average selling price of premium ablation technology. All these things increase the deployment cost of the ablation technology. Some of the key players in the market include Medtronic, Boston Scientific Corporation, Angiodynamics, Inc., Atricure, Inc., Olympus Corporation, Smith & Nephew, Varian Medical Systems, CardioFocus, Auris Health, Inc., Stereotaxis,Inc., and Others.
Trends and Future Outlook:
- In April 2021, Olympus Corporation shifted their global headquarters of its Therapeutic Solutions Division from Tokyo to the US.
- In January 2019, Medtronic acquired EPIX Therapeutics, Inc. (EPIX), which manufactures a catheter-based, temperature-controlled cardiac ablation system.
- Growing government investment in advancement of medical industry in recent years.
- In recent years, advancement in healthcare sector have become a major trend and ablation technology is going to help for advancement.